Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis

Veldt BJ, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, Zeuzem S, et al. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Ann Intern Med. 2007;147(10):677-684.

Publication Type:

Journal Article

Authors:

Veldt, B.J.; Heathcote, E.J.; Wedemeyer, H.; Reichen, J.; Hofmann, W.P.; Stefan Zeuzem; Manns, M.P.; Hansen, B.E.; Schalm, S.W.; H L Janssen

Source:

Ann Intern Med, Volume 147, Issue 10, p.677-684 (2007)

Keywords:

Adult, Antiviral Agents, blood, Canada, Carcinoma, Carcinoma,Hepatocellular, Cohort Studies, complications, Death, drug therapy, Drug Therapy,Combination, etiology, Europe, Female, Fibrosis, Follow-Up Studies, hepatitis, Hepatitis C, hepatitis C virus, Hepatitis C,Chronic, Humans, Infection, interferon, Interferon Alfa-2b, Interferon-alpha, Liver, Liver Cirrhosis, Liver Failure, Liver Neoplasms, Liver Transplantation, Male, Middle Aged, Mortality, Multicenter Studies, Netherlands, Patients, prevention, Proteins, Recombinant Proteins, Retrospective Studies, Ribavirin, Rna, Rna,Viral, Survival, sustained virologic response, therapeutic use, treatment, Treatment Outcome, virology

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/18025443

Export Citation:

RIS Format

Top